Esaote Introduces New MyLab E85 GTS Ultrasound System

Esaote has launched a new cart-based ultrasound system—MyLab E85 GTS—that combines two technologies for the first time: Virtual Navigator and Ablation Confirmation.

Virtual Navigator enables real-time multimodality image fusion for accurate navigation, reinforcing the role of ultrasound as a valuable aid to computed tomography (CT)-guided interventional procedures. Ablation Confirmation analyzes and combines pre- and post-treatment CT and multiparametric MRI data with real-time ultrasound imaging automatically to assess the technical success of thermal ablation procedures. The combination of both technologies aims to provide interventional radiologists with accurate diagnosis, excellent needle visualization, and improved interventional procedures. 

“Interventional procedures can be done under CT guidance, but allying them with ultrasound systems, characterized by non-radiation procedures and real time-imaging, offers invaluable advantages: With a single click, the fusion between CT and US images is operational,” explained Marta Daniel, Guided Therapy Product and Clinical Solutions manager at Esaote. “By maximizing the workflow of focal ablation, MyLab E85 GTS offers the first ‘integrated’ Ablation Confirmation Software in addition to fusion imaging. The software analyses pre- and post-ablation CT scans and provides feedback on the effectiveness of the procedure, maintaining real-time fused images to navigate the target area, both to confirm treatment and to further ablate any residual areas identified. This is a breakthrough that ensures confidence and precision.” 

Equipped with a touch-sensitive keyboard that is easy to clean, MyLab E85 GTS represents a further evolution in currently available devices for specialists, offering patients greater precision in minimally invasive therapeutic and diagnostic procedures. The Virtual Navigator-Ablation Confirmation mix guarantees high performance in biopsies, aspirations, and drainages, according to the company. Needle visualization is excellent and boosts physician confidence in surgical precision. 

Esaote developed the new MyLab E85 GTS to address interventional radiology needs. “Working with young physicians all around the world, we identified their challenges and understood their specific requests, pushing us to go beyond the conventional functions of an ultrasound system”, said Laurent Rapon, global business development manager, GTS US. “The E85 GTS is our first response to this commitment, proposing a sealed keyboard design and integrating tailor-made software to further ease complex interventional procedures.”

Esaote manufacturers medical diagnostic systems. The company identifies itself as a leader in dedicated magnetic resonance imaging and a main player in healthcare information technology. Ultrasound is its core business, but Esaote also competes in the interventional sector. Since its early 1980s founding, Esaote has grown to become a global company; it is headquartered in Genoa, Italy, and maintains a presence in around 100 countries. Esaote operates research centers and production plants in Italy and the Netherlands, along with subsidiaries and offices in France, Germany, Spain, the United Kingdom, the Netherlands, Russia, the United States, China, Argentina, India, Brazil, and Mexico. The Esaote Group employs more than 1,250 workers, 20% of whom are engaged in Research & Development, a sector in which it has always invested between 10% and 12% of its annual revenues.